Life Sciences Diagnostic & Therapeutic Devices sector
Strategic acquirers, private equity (buyout funds and growth funds) firms, and valuation benchmarks for Life Sciences Diagnostic & Therapeutic Devices
1.1 - About Life Sciences Diagnostic & Therapeutic Devices sector
Companies in the Life Sciences Diagnostic & Therapeutic Devices category design, manufacture, and integrate clinical equipment that enables precise diagnosis and effective treatment across hospital and outpatient settings. These strategic buyers provide radiation therapy systems, interventional imaging-enabling devices, patient monitoring, surgical tools, and medication management platforms to improve clinical accuracy, workflow efficiency, and patient safety. M&A analysts use this category to identify strategic buyers in medical devices with diversified care delivery solutions.
Vendors in this space span high‑acuity therapy and diagnostics, delivering proton radiation therapy platforms alongside interventional imaging devices supported by contrast agents. They offer ambulatory and wearable ECG/EEG monitoring for remote diagnostics, and surgical closure solutions such as sutures, clips, adhesives, and sealants for hemostasis. Capabilities extend to rapid infusion and fluid warming systems, medication management carts and secure dispensing cabinets, dental implant systems with guided planning software, and clinic-based neuromodulation equipment for TMS.
Primary customers include hospitals and health systems, specialty outpatient clinics and surgical centers, and diagnostic imaging facilities. Outcomes commonly delivered are higher diagnostic confidence, reduced procedural complications, streamlined clinical workflows with bedside data access and automated dispensing, and improved patient safety through controlled therapy delivery and monitoring. These companies also support compliance with evolving device regulations while lowering total cost of care through interoperable, durable platforms.
2. Buyers in the Life Sciences Diagnostic & Therapeutic Devices sector
2.1 Top strategic acquirers of Life Sciences Diagnostic & Therapeutic Devices companies
Laborie
- Description: Provider of diagnostic and therapeutic medical devices focused on gastroenterology, urology, urogynecology and obstetrics, gynecology & neonatal care. The privately owned firm manufactures high-quality, high-impact products and supports them with clinical education, enabling clinicians and hospitals to improve patient outcomes through progressive technology and best practices.
- Key Products:
- Diagnostic Equipment: Advanced devices for urology, gastroenterology, gynecology, obstetrics and neonatology, enabling accurate clinical assessment and informed treatment decisions for healthcare professionals
- Consumable Supplies: Specialty disposables engineered for compatibility with Laborie diagnostic systems, ensuring reliable test results and consistent patient care across multiple medical disciplines
- Optilume® Urethral Drug-Coated Balloon: Minimally invasive balloon catheter delivering drug therapy to treat urethral strictures, now covered by BCBSM, improving stricture outcomes and expanding evidence-based care access
- Comprehensive OB Product Suite: Integrated obstetric solutions supporting the full continuum from antenatal through postpartum, neonatal and gynecological surgical procedures, enhancing efficiency and patient safety throughout childbirth care.
- Rationale: Provider of advanced urology/gastroenterology diagnostic equipment, Optilume Urethral Drug-Coated Balloon stricture therapy, and comprehensive OB suite for perinatal care.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
2.2 - Strategic buyer groups for Life Sciences Diagnostic & Therapeutic Devices sector
M&A buyer group 1: Diversified Medical Devices
Johnson & Johnson
- Type: N/A
- Employees: ●●●●●
- Description: Provider of pharmaceutical products and medical devices addressing immune disorders, cancer, neurological, infectious, cardiovascular and metabolic diseases, plus technologies for cardiovascular, orthopedic, neurovascular, general surgery and vision care; engaged in research, development, manufacturing and global sale of medicines and medical technologies to retailers, wholesalers, healthcare professionals and hospitals.
- Key Products:
- Pharmaceutical Therapeutics Portfolio: Treatments targeting immune disorders, cancer, neurological, infectious, cardiovascular and metabolic diseases, developed and manufactured for prescription use by healthcare professionals
- Cardiovascular & Orthopedic Medical Devices: Implantable devices and surgical instruments for cardiovascular interventions, orthopedic reconstruction and neurovascular care, enhancing surgical precision and patient outcomes
- General & Vision Surgery Technologies: Instruments and equipment supporting general surgery and vision care procedures, delivering advanced functionality that improves clinical efficiency and patient recovery
- Consumer Health Brands (Johnson’s
- Benadryl
- Listerine): Over-the-counter medicines and personal care lines offering baby care, allergy relief and oral hygiene, distributed through global retail and wholesale channels.
Buyer group 2: ████████ ████████
●● companiesBuyer group 3: ████████ ████████
●● companies3. Investors and private equity firms in Life Sciences Diagnostic & Therapeutic Devices sector
3.1 - Buyout funds in the Life Sciences Diagnostic & Therapeutic Devices sector
2.2 - Strategic buyer groups for Life Sciences Diagnostic & Therapeutic Devices sector
4 - Top valuation comps for Life Sciences Diagnostic & Therapeutic Devices companies
4.2 - Public trading comparable groups for Life Sciences Diagnostic & Therapeutic Devices sector
Valuation benchmark group 1: Surgical Systems and Devices Manufacturers
Intuitive Surgical
- Enterprise value: $●●●m
- Market Cap: $●●●m
- EV/Revenue: ●.●x
- EV/EBITDA: ●●.●x
- Description: Provider of robotic-assisted surgical systems and related instruments that enhance the ability of doctors to perform complex surgeries using minimally invasive techniques. Develops, manufactures, and markets the da Vinci Surgical System, offering improved clinical outcomes and greater access to definitive care.
- Key Products:
- da Vinci Surgical System: Robotic-assisted platform that enhances surgeons’ capabilities in performing complex procedures
- EndoWrist Instruments: Surgical instruments designed for use with the da Vinci Surgical System
- E-200 Generator: High-frequency energy generator for cutting, coagulation, and rapid vessel sealing
- Firefly Imaging System: Advanced imaging technology for enhanced visualization during surgery
- Training Programs: Comprehensive training and education services for healthcare providers